Savara develops pulmonary drug delivery solutions based on an exclusive license of the nanocluster formulation technology developed at the University of Kansas. Savara was founded in March 2007 in Lawrence by Dr. Cory Berkland, inventor of the delivery platform, and George Laurence, President and Chief Technology Officer.